Project Grant K23DA063832
Award Date
8/1/25
Completion Date
7/31/30
Dollars Obligated
$179K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
This $2,118,992 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study investigating the neural and psychiatric consequences of cannabis use in depressed adolescents. The research aims to prospectively examine the effects of cannabis, the most widely used illicit drug among teenagers, on reward and pain neurocircuits in adolescents with depression. The study will evaluate 250...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $621,186 longitudinal study to examine the impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the Adolescent Brain Cognitive Development (ABCD) study. The 5-year study, running from July 2025 to March 2030, will be conducted by the University of...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,980,270 to the Regents of the University of Minnesota to conduct an observational study on the neurobehavioral impacts of medical cannabis use. The study aims to assess cognition, neural function, and substance use disorder (SUD) risk in 120 medical cannabis patients in Minnesota compared to 60 non-cannabis using controls. It will...
This federal Project Grant award of $360,100.00 was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to George Washington University. The funding will support research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project aims to investigate the increasing use of cannabis and derived psychoactive cannabis products,...
This Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to study the effects of cannabis use on treatment outcomes for adolescents with alcohol use disorder (AUD) and co-occurring psychiatric disorders (CODs) in community-based treatment settings. The $197,262 award will leverage mixed methods, including qualitative interviews, an ecological momentary assessment pilot, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,383,618.00 in funding to The Johns Hopkins University to conduct research on the microglia-mediated adverse effects of cannabis (specifically delta-9-tetrahydrocannabinol or THC) on the maturation of the prefrontal cortex and cognitive function during adolescence. The research aims to elucidate the molecular and cellular mechanisms by which THC...
This federal Project Grant award of $800,617.00, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and validation of neuromarkers - measurable, brain-based indicators of pathophysiology, risk, and resilience related to substance use disorders (SUDs). The project, titled "NEUROMARKERS FOR CRAVING AND DRUG USE", aims to build upon previous research that created a cross-validated neuromarker...
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $684,694 to New York University School of Medicine to develop and evaluate a telehealth-delivered transcranial direct current stimulation (tDCS) intervention combined with mindfulness meditation for treating cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S....
This $441,000 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support research at Yale University to investigate the molecular changes in the brain that link cannabis use disorder and major depressive disorder. The researchers will use innovative single-cell genomics to identify transcriptomic and chromatin alterations in two key brain regions from 120 donors with cannabis use disorder, major...